Hansa Biopharma AB (HNSBF) Ownership Overview
The ownership structure of Hansa Biopharma AB (HNSBF) stock is a mix of institutional, retail, and individual investors. , and 98.64% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,176,800 | Institution | 1.16% | 4,354,160 | |
| 210,613 | Institution | 0.21% | 779,268 | |
| 65 | Institution | <0.01% | 241 | |
| 2 | Institution | <0.01% | 7 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,176,800 | Institution | 1.16% | 4,354,160 | |
| 2 | Institution | <0.01% | 7 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Hansa Biopharma AB (HNSBF)?
Currently, no data Available
What percentage of Hansa Biopharma AB (HNSBF) stock is held by institutional investors?
Currently, no data Available
What percentage of Hansa Biopharma AB (HNSBF) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.64% of Hansa Biopharma AB (HNSBF) stock is held by retail investors.
Who owns the most shares of Hansa Biopharma AB (HNSBF)?
Fidelity Select Portfolios owns the most shares of Hansa Biopharma AB (HNSBF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.